References
- 1. Damoiseaux JG, Tervaert JW. The definition of autoimmune disease: are Koch’s postulates applicable? Neth J Med, 2002, 60:266-268.
- 2. Wållberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol, 2013, 34, 583-591.
- 3. Wentworth JM, Fourlanos S, Harrison LC. Reappraising the stereotypes of diabetes in the modern diabetogenic environment. Nat Rev Endocrinol, 2009, 5, 483-489.
- 4. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med, 2001, 344, 655-664.
- 5. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001, 13, 114-11.
- 6. Winer DA, Winer S, Shen L, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med, 2011, 17, 610-617.
- 7. Turner R, Stratton I, Horton V, et al. UK Prospective Diabetes Study Group. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet, 1997, 350, 1288-1293.
- 8. Brooks-Worrell B, Narla R, Palmer JP. Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obes Metab, 2013, 15(Suppl. 3), 137-140.
- 9. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med, 2009,15, 930-939.
- 10. Strissel KJ, DeFuria J, Shaul ME еt al. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity, 2010,18, 1918-1925.
- 11. Fabbrini E, Cella M, McCartney SA, et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology, 2013, 145, 366-374.
- 12. McLaughlin T, Liu LF, Lamendola C, et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol, 2014,34, 2637-2643.
- 13. Butcher MJ, Hallinger D, Garcia E, et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia, 2014, 57, 491-501.
- 14. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 2011,11, 98-107.
- 15. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia, 2001, 44, 914–922
- 16. Tuomi T, Carlsson A, Li H et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetesq 1999, 48, 150-7.
- 17. Diagnosis and Classification of Diabetes Mellitus. Diabetes, Care, 2011, 34(Suppl 1), 62-69.
- 18. Thomas G. Pickering, MD et al. Recomendation for blood pressure measurment in humans and experimental animals, Hypertension, 2004, 45, 142.
- 19. Haider K. Zaidan, Israa H. Ibrahim, Ali H. Al Saadi, Mufeed J.Ewadh, Qasim M. Ali Al Ameri Total and differential leukocytes count in type 2 diabetes mellitus patients in Iraq. Research in Biotechnology, 2012, 3(2)1, 32-40.
- 20. Menart- Houtermans B., Rütter R, Nowotny B et al. Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS). Diabetes Care, 2014, 37(8), 2326-2333.
- 21. Bradshaw EM, Raddassi K, Elyaman W. et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. Journal of immunology, 2009, 183, 4432-9.
- 22. Zak K.P., Mankovsky B.M., Kondratska I.N et al. Afanasyeva Immunity in patients with type 2 diabetes mellitus with concomitant metabolic syndrome/obesity. Communication 1. Composition of blood leukocytes, immunophenotype of lymphocytes, and ultrastructure of neutrophils. Endokrynologia, 2013, 18 (1), 27-36.
- 23. Jason De Furiaa, Anna C. Belkinab, Madhumita Jagannathan-Bogdanc et al. B Cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. PANAS, 2010, 110, 5133-5138.